
RFK Jr. Gives First Speech to HHS Staff, Focusing on His Priorities
Five days after taking the oath of his office, Robert F. Kennedy Jr. addressed HHS staffers
Five days after taking the oath of his office, Robert F. Kennedy Jr. addressed HHS staffers
This year, venture capitalists in the digital health landscape have many more quality investment opportunities than they did in the past couple years, according to Oak HC/FT Partner Billy Deitch. He noted that many startups have been preserving the capital over the past two years with the plan to raise funds in 2025. The post…
Highmark and Sword Health launched a new virtual pelvic health offering on Monday. The program connects members with a pelvic health specialist. The post Highmark Launches Virtual Pelvic Health Offering Powered by Sword Health appeared first on MedCity News.
When Colleen Henderson’s 3-year-old daughter complained of pain while using the bathroom, doctors brushed it off as a urinary tract infection or constipation, common maladies in the potty-training years. After being told her health insurance wouldn’t cover an ultrasound, Henderson charged the $6,000 procedure to her credit card. Then came the news: There was a…
Physician enablement company offers national clinical leadership program
Shortly after 1,000 Indian Health Service workers were let go, the layoffs affecting them were rescinded
Yasir Tarabichi, M.D., chief health AI officer at MetroHealth, shares his perspectives
This issue brief provides an overview of what Medicaid home care (also known as “home- and community-based services” or HCBS) is, who is covered, and what services were available in 2024.
This issue brief describes states’ ongoing efforts to respond to shortages of home care workers and how they pay these workers, finding that increased payment rates are a key component of states’ efforts to address workforce shortages.
Romvimza, a drug for treating tenosynovial giant cell tumor, was initially developed by Deciphera Pharmaceuticals. Last year, Ono Pharmaceutical acquired Deciphera to build up its oncology portfolio and expand its business prospects in the U.S. and Europe. The post Ono Pharma Drug Acquired in $2.4B Deal Wins FDA Approval for Treating Rare Type of Tumor…